Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

May 21, 2024

BUY
$0.58 - $1.47 $1,330 - $3,372
2,294 Added 101.87%
4,546 $2,000
Q3 2023

Oct 30, 2023

BUY
$0.58 - $1.47 $1,330 - $3,372
2,294 Added 101.87%
4,546 $3,000
Q2 2023

May 21, 2024

SELL
$1.11 - $1.74 $34 - $53
-31 Reduced 1.36%
2,252 $2,000
Q2 2023

Jul 27, 2023

SELL
$1.11 - $1.74 $34 - $53
-31 Reduced 1.36%
2,252 $3,000
Q1 2023

May 21, 2024

BUY
$1.66 - $3.67 $1,025 - $2,268
618 Added 37.12%
2,283 $4,000
Q1 2023

Apr 27, 2023

BUY
$1.66 - $3.67 $1,025 - $2,268
618 Added 37.12%
2,283 $4,000
Q4 2022

May 21, 2024

BUY
$2.77 - $5.07 $4,612 - $8,441
1,665 New
1,665 $5,000
Q4 2022

Jan 31, 2023

BUY
$2.77 - $5.07 $551 - $1,008
199 Added 13.57%
1,665 $5,000
Q3 2022

Oct 21, 2022

BUY
$4.27 - $6.39 $6,259 - $9,367
1,466 New
1,466 $7,000

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $193M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.